Dongmei Zuo

3.3k total citations
54 papers, 2.2k citations indexed

About

Dongmei Zuo is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Dongmei Zuo has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Physiology. Recurrent topics in Dongmei Zuo's work include Microbial metabolism and enzyme function (7 papers), Ubiquitin and proteasome pathways (6 papers) and Liver physiology and pathology (5 papers). Dongmei Zuo is often cited by papers focused on Microbial metabolism and enzyme function (7 papers), Ubiquitin and proteasome pathways (6 papers) and Liver physiology and pathology (5 papers). Dongmei Zuo collaborates with scholars based in Canada, United States and China. Dongmei Zuo's co-authors include P. H. Yu, Peter H. Yu, Morag Park, William J. Muller, Jianyin Long, Virginie Sanguin‐Gendreau, Heng Fan, Xingxing Liu, Joshua LaBaer and Qing Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Dongmei Zuo

52 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongmei Zuo Canada 27 1.6k 385 329 311 214 54 2.2k
Xiliang Zha China 26 1.1k 0.7× 273 0.7× 292 0.9× 258 0.8× 242 1.1× 78 1.8k
Laura Moro Italy 23 1.1k 0.7× 436 1.1× 225 0.7× 408 1.3× 190 0.9× 55 2.2k
Michał Bieńkowski Poland 24 1.2k 0.7× 322 0.8× 312 0.9× 271 0.9× 271 1.3× 80 2.3k
Roch‐Philippe Charles Switzerland 22 1.0k 0.7× 447 1.2× 342 1.0× 137 0.4× 240 1.1× 35 1.9k
Elizabeth J. Ackermann United States 18 1.9k 1.2× 416 1.1× 181 0.6× 410 1.3× 270 1.3× 35 2.4k
Sang-Oh Yoon United States 21 2.0k 1.2× 584 1.5× 570 1.7× 393 1.3× 240 1.1× 30 2.8k
Yiping Tu United States 26 2.0k 1.3× 466 1.2× 275 0.8× 425 1.4× 240 1.1× 53 3.1k
Motoko Shibanuma Japan 31 2.2k 1.4× 367 1.0× 501 1.5× 543 1.7× 439 2.1× 67 3.3k
Christopher Belham United Kingdom 15 2.3k 1.4× 287 0.7× 272 0.8× 629 2.0× 309 1.4× 16 3.0k
Valeria Bertagnolo Italy 25 1.5k 1.0× 345 0.9× 256 0.8× 356 1.1× 202 0.9× 85 2.0k

Countries citing papers authored by Dongmei Zuo

Since Specialization
Citations

This map shows the geographic impact of Dongmei Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongmei Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongmei Zuo more than expected).

Fields of papers citing papers by Dongmei Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongmei Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongmei Zuo. The network helps show where Dongmei Zuo may publish in the future.

Co-authorship network of co-authors of Dongmei Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Dongmei Zuo. A scholar is included among the top collaborators of Dongmei Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongmei Zuo. Dongmei Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Smith, Harvey W., Virginie Sanguin‐Gendreau, Alain Pacis, et al.. (2023). Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression. Journal of Clinical Investigation. 133(7). 19 indexed citations
3.
Xiao, Bin, Harvey W. Smith, Dongmei Zuo, et al.. (2023). Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways. Proceedings of the National Academy of Sciences. 120(33). e2303010120–e2303010120. 14 indexed citations
4.
Bui, Tung, Dongmei Zuo, Virginie Sanguin‐Gendreau, et al.. (2022). Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer. Oncogene. 41(25). 3445–3451. 3 indexed citations
5.
Deng, Shuangjiao, Hongfei Wang, Heng Fan, et al.. (2018). Over-expressed miRNA-200b ameliorates ulcerative colitis-related colorectal cancer in mice through orchestrating epithelial-mesenchymal transition and inflammatory responses by channel of AKT2. International Immunopharmacology. 61. 346–354. 18 indexed citations
6.
Yang, Jia, Chengzhi Zhou, Rui Zhu, et al.. (2017). miR‐200b‐containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial‐mesenchymal transition. Journal of Gastroenterology and Hepatology. 32(12). 1966–1974. 66 indexed citations
7.
Rao, Tadimeti S., et al.. (2017). ErbB2-positive mammary tumors can escape PI3K-p110α loss through downregulation of the Pten tumor suppressor. Oncogene. 36(43). 6059–6066. 6 indexed citations
8.
Bell, Emily, Charles Vincent Rajadurai, Sean Cory, et al.. (2012). Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Breast Cancer Research. 14(3). R74–R74. 50 indexed citations
9.
Rajadurai, Charles Vincent, Kossay Zaoui, Matthew Stuible, et al.. (2012). Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia. Journal of Cell Science. 125(Pt 12). 2940–53. 56 indexed citations
10.
Rolfs, Andreas, Yanhui Hu, Lars Ebert, et al.. (2008). A Biomedically Enriched Collection of 7000 Human ORF Clones. PLoS ONE. 3(1). e1528–e1528. 20 indexed citations
11.
Ursini‐Siegel, Josie, Ashish Rajput, Virginie Sanguin‐Gendreau, et al.. (2007). Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development. Molecular and Cellular Biology. 27(18). 6361–6371. 45 indexed citations
12.
Murthy, Tal V., Andreas Rolfs, Yanhui Hu, et al.. (2007). A Full-Genomic Sequence-Verified Protein-Coding Gene Collection for Francisella tularensis. PLoS ONE. 2(6). e577–e577. 20 indexed citations
13.
Rolfs, Andreas, et al.. (2007). A novel approach to sequence validating protein expression clones with automated decision making. BMC Bioinformatics. 8(1). 198–198. 6 indexed citations
14.
Rodrigues, Sonia, et al.. (2005). CrkI and CrkII Function as Key Signaling Integrators for Migration and Invasion of Cancer Cells. Molecular Cancer Research. 3(4). 183–194. 63 indexed citations
15.
Khoury, Hanane, Monica A. Naujokas, Dongmei Zuo, et al.. (2004). HGF Converts ErbB2/Neu Epithelial Morphogenesis to Cell Invasion. Molecular Biology of the Cell. 16(2). 550–561. 94 indexed citations
16.
LaBaer, Joshua, Anukanth Anumanthan, Dongmei Zuo, et al.. (2004). The Pseudomonas aeruginosa PA01 Gene Collection. Genome Research. 14(10b). 2190–2200. 72 indexed citations
17.
Yu, P. H. & Dongmei Zuo. (1997). Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia. 40(11). 1243–1250. 106 indexed citations
18.
Yu, P. H. & Dongmei Zuo. (1996). Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atherosclerosis. 120(1-2). 189–197. 81 indexed citations
19.
Zhang, Xia, et al.. (1996). MK-801 induces apoptotic neuronal death in the rat retrosplenial cortex: Prevention by cycloheximide and R(?)-2-Hexyl-N- Methylpropargylamine. Journal of Neuroscience Research. 46(1). 82–89. 22 indexed citations
20.
Yu, P. H., Bárbara Davis, A. A. Boulton, & Dongmei Zuo. (1994). Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. PubMed. 41. 397–406. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiliang Zha Breakdown of academic impact, for papers by Laura Moro Breakdown of academic impact, for papers by Michał Bieńkowski Breakdown of academic impact, for papers by Roch‐Philippe Charles Breakdown of academic impact, for papers by Elizabeth J. Ackermann Breakdown of academic impact, for papers by Sang-Oh Yoon Breakdown of academic impact, for papers by Yiping Tu Breakdown of academic impact, for papers by Motoko Shibanuma Breakdown of academic impact, for papers by Christopher Belham Breakdown of academic impact, for papers by Valeria Bertagnolo
Rankless by CCL
2026